INTRODUCTION RESULTS

5 4
Levofloxacin (MICs 0.031 µg/ml) and cefotaxime (MICs 0.125 µg/ml) were the most active 1 5 5 agents tested and all isolates were fully susceptible to these agents. were 16-256 µg/ml. In this study, the production of TEM-1 encoded β-lactamase was the most 1 6 8 prevalent mechanism of ampicillin-resistance in H. influenzae. 1 6 9 1 7 0
In the BLNAR strains, MIC 50 of ampicillin, amoxicillin/clavulante, and cefuroxime were 2-4-1 7 1
fold higher than those for the BLNAS strains. In the BLPACR strains, the MIC 50 of ampicillin,
amoxicillin/clavulanate, and cefuroxime were about 4-fold higher than those for the BLNAS 1 7 3
strains. Compared with the MIC range between BLNAR and BLPACR strains, there were no 1 7 4
differences in the MICs of amoxicillin/clavulanate, cefaclor, cefuroxime, and cefotaxime.
7 5
However, the BLNAR strains had relatively lower MICs of ampicillin (2-8 µg/ml) than those of 1 7 6
BLPACR (4->512 µg/ml) strains.
Amino acid substitutions of PBP3 in BLNAR and BLPACR strains.
7 9
The nucleotide sequences of the ftsI gene were determined for 33 BLNAR and 28 BLPACR In the BLPACR isolates, the most prevalent substitutions were Asp350Asn, Met377Ile, 1 9 3
Ala502Val/Thr, and Asn526Lys, all of which were present in the BLNAR strains. A total of 1 9 4
92.9% belonged into group II, whereas only 7.1% belonged into group I. No strain classified as 1 9 5
group III was evident in the BLPACR strains. Compared with BLNAR strains, BLPACR 1 9 6
isolates had similar patterns in PBP3 amino acid substitution. 1 9 7 1 9 8
PFGE patterns of BLNAR and BLPACR strains.
9 9
The genetic relatedness of BLNAR and BLPACR strains of H. influenzae was investigated by 2 0 0
cluster analysis using PFGE. Isolates with greater than 85% similarity were grouped into the 2 0 1 same PFGE cluster. There were no epidemiological links between the 33 BLNAR and 28 2 0 2 BLPACR isolates, which were isolated from different patients from several geographically-2 0 3 dispersed clinics throughout Korea. As shown in the dendrogram (Fig. 1 The high prevalence of antimicrobial resistance in major respiratory pathogens has led to 2 2 8 serious concern in the selection of an appropriate antimicrobial agent for the empirical treatment 2 2 9
of RTIs worldwide. With the high rate of β-lactamase in H. influenzae, amoxicillin/clavulanate 2 3 0 and oral cephalosporins have been widely used for oral antibiotic treatments for outpatients with 2 3 1
RTIs at private-sector hospitals in Korea. Although β-lactamase production is regarded as the 2 3 2 major mechanism of ampicillin resistant H. influenzae, there can be enormous regional 2 3 3 differences and changes in β-lactamase prevalence, ranging from 3% in Germany up to 65% in 2 3 4
Korea (10, 18).
3 5 3 6
In this study, β-lactamase production (52.4%) was the main mechanism of ampicillin resistance 2 3 7
of H. influenzae. In β-lactamase-positive strains, the prevalence of TEM-1 and ROB-1 was 2 3 8
94.7% and 3.2%, which is similar to the report in global survey from PROTEKT study (18).
3 9
Also, two isolates, with ampicillin MIC of 64-128 µg/ml, were positive for nitrocefin hydrolysis prevalence has increased in some countries including Japan, Spain, and France (6, 18).
5 0
Particularly, in Japan, recent surveillance data indicates that BLNAR isolates have exponentially 
